Unbound MEDLINE

Early intralipid therapy may have prevented bupivacaine-associated cardiac arrest. Regional anesthesia and pain medicine [Reg Anesth Pain Med] Journal article

 
TitleEarly intralipid therapy may have prevented bupivacaine-associated cardiac arrest.
Author(s)McCutchen T, Gerancher JC 
InstitutionDepartment of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, NC.
SourceReg Anesth Pain Med 2008 Mar-Apr; 33(2):178-80.
AbstractOBJECTIVE: Local anesthetic-induced cardiotoxicity remains a complication of regional anesthesia, with the potential to result in cardiac arrest refractory to resuscitation. Successful resuscitation using Intralipid (Baxter Pharmaceuticals by Fresenius Kabi, Uppsala, Sweden), has been reported in 2 patients with bupivacaine-induced cardiac arrest.
CASE REPORT: We report another case for which Intralipid was used as part of a successful resuscitation in a patient with local anesthetic-induced cardiotoxicity.
CONCLUSIONS: Early treatment with Intralipid may help prevent cardiac arrest and speed successful resuscitation efforts.
Languageeng
Pub Type(s)Journal Article
PubMed ID18299100
  
Advertise on this site.